glp-1 medications in weight management The revolution: What UAB researchers are discovering about how these drugs work Market Overview: GLP-1 Agonists and

Importantly, patients using transdermal medications should avoid exposing the patch to external heat sources such as heating pads, electric blankets, hot tubs, saunas, or prolonged direct sunlight, as heat can increase drug absorption and potentially cause overdose

Gradual return to activity as pain allows

B12 shots are safe when administered by a healthcare professional following proper guidelines and precautions

Known for its repairing properties, GHK-Cu helps reduce redness while promoting a more youthful, radiant complexion

Brill AL, Wisinski JA, Cadena MT, Thompson MF, Fenske RJ, Brar HK, et al

Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice